SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Video: Carolina Calling - Eric Church Interview
Tommy Ashley and Joey Powell of inside Carolina speak with Tar Heel super-fan and 11-time Grammy nominee Eric Church about the Bill Belichick experiment in...
Tue Oct 27, 2026

Former UNC student Faith Hedgepeth's killer sentenced to life in prison without parole
A jury found Miguel Salguero-Olivares guilty of first-degree murder, first-degree rape, first-degree sexual offense, and first-degree burglary in the killing of UNC student Faith Hedgepeth...
Sat Oct 24, 2026

Video: The Road from Chapel Hill to Nashville with Chase Rice
North Carolina alumnus, former Tar Heel linebacker, and country music artist Chase Rice joins the Well Said podcast to talk about how his time at...
Fri Oct 23, 2026

Michael Jordan’s historic $10 million gift honors mother, expands UNC School of Social Work’s impact
In honor of his mother, Deloris P. Jordan, Michael Jordan has made a $10 million commitment to the UNC School of Social Work. The largest...
Mon Oct 5, 2026